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Endometriosis is defined as the presence of en-
dometrial-like tissue outside the uterus and is of-
ten associated with infertility and significant pain 
[1], though malignant transformation is rare [2]. 
It is estimated that up to 10% of all women of re-
productive age are affected by endometriosis [3], 
though the true prevalence is uncertain as definitive 
diagnosis requires surgical evaluation. Treatment 
for endometriosis may be medical, surgical, or 
both, depending on response and treatment goals. 
Medical treatment typically involves an oral con-
traceptive pill (either combined or progestin only) 
or a gonadotropin-releasing hormone agonist. The 
surgical approach, which is often considered after 
failure of hormone therapy, is aimed at complete 
removal or destruction of endometriotic lesions 
[1, 4]. Unfortunately, post-treatment persistence or 
recurrence of symptoms is not uncommon, regard-
less of treatment approach [1, 5, 6]. 
Literature describing the management of in-
operable and medically refractive endometriosis 
with radiation is limited to a handful of case re-
ports [7–12], and fewer still that report radiation 
targeted specifically at residual endometriotic tis-
sue. These publications report successful pain and 
bleeding control [7, 8]. Here, we present a case 
of a patient with vaginal bleeding secondary to 
hormone-refractory and inoperable endometrio-
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sis who was successfully treated with radiation 
therapy.
case presentation
A 39-year-old woman, G0 P0000, with a history 
of endometriosis and obesity (body mass index 49.6 
kg/m²) presented with vaginal bleeding. The patient 
had a long history of endometriosis for the last 
10 years initially treated medically but eventually 
requiring total abdominal hysterectomy with bilat-
eral salpingo-oophorectomy at an outside facility 
8 years prior to the current presentation. She was 
doing well until 3 years ago when she developed 
vaginal bleeding with associated pelvic pain. Medi-
cal therapy with a gonadotropin-releasing hormone 
agonist was given for 3 months with no relief in 
symptoms. After that, an examination under anes-
thesia showed a 3 cm nodule at the top of the vagina 
and biopsy was consistent with endometriosis.
She subsequently underwent robotic resection 
of that nodule, but her postoperative course was 
complicated by the development of a vesicovaginal 
fistula that required surgical correction by urology. 
Her bleeding temporarily subsided, but returned 
after 6 months. She was prescribed elagolix (Orl-
issa), but noted no relief in her symptoms after 
several months. The gynecologic oncologist did not 
recommend further surgery given the vesicovaginal 
fistula requiring surgical repair in the past. Because 
all conventional treatment options were exhausted, 
she was referred for possible radiation treatment.
At current presentation, she noted continued in-
termittent bleeding (requiring 2 pads per day on 
days of bleeding) and pelvic pain from the endo-
metriosis. Bimanual exam showed a small tender 
nodularity in the vaginal cuff with a small amount 
of oozing blood. A discussion was had with the 
patient to create a plan of action. Given that she 
had received multiple lines of medical and surgi-
cal resection with recurrence of her vaginal bleed-
ing, radiation treatment was offered. The risks, 
benefits, side effects, and potential complications 
of radiation treatment, including increased risk of 
secondary malignancy, were discussed. An MRI of 
the pelvis was obtained to determine the extent of 
her endometriosis, and it showed a 3.0 × 2.3 × 2.9 
cm soft tissue mass at the vaginal apex (shown in 
Fig.  1). The patient was consented for radiation 
treatment, and a CT simulation was conducted with 
both a full and empty bladder. An  internal gross 
target volume (iGTV) was created from contour-
ing and  merging GTV volumes  from both scans. 
A clinical target volume (CTV) was not created due 
to low concern for microscopic disease and this be-
ing a benign entity. A uniform 15 mm expansion in 
all directions was done to create a planning target 
volume (PTV). She was prescribed 30 Gy in 10 frac-
tions, and 10 MV and 18 MV photons were used to 
ensure that 100% of the prescription dose covered 
95% of the target volume (Fig. 2). Organs at risk 
(OAR) that were monitored included the bladder, 
bowel, femurs, and rectum. During weekly check-
ups, the patient noted improvement in her bleeding 
with only a small amount of blood with urination. 
At follow-up, the patient reported that her vagi-
nal bleeding completely resolved 1 week after ra-
diation treatment completion. She had not had any 
bleeding since. She also reported resolution of her 
pelvic pain. She reported this had been the longest 
period she had had without bleeding in 2 years, 
and she was very pleased with the results. She de-
nied any lingering side effects and speculum exam 
showed normal vaginal mucosa and no residual 
endometriosis tissue at the vaginal cuff.
Discussion
This report joins a small number of case reports 
[7–12] that discuss the management of refractory 
endometriosis with radiation therapy. Most of these 
case reports describe radiation treatment with the 
Figure 1. refractory endometriosis on imaging. axial 
t1 post-contrast MrI view showing a 3.0 × 2.3 × 2.9 cm 
biopsy-proven endometriosis mass at the vaginal apex
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goal of ovarian ablation [9, 10] or destruction of 
symptomatic ovarian remnants [11, 12], as opposed 
to direct delivery to endometriotic tissue as in this 
report. Bleeding and pelvic pain were successfully 
controlled in our patient at follow up, suggesting 
that radiation may be used to control bleeding in 
cases where there is no detectable, remaining ovar-
ian tissue.
Our patient was a 39-year-old woman with medi-
cally refractive endometriosis who was not a can-
didate for surgery due to a history of vesicovaginal 
fistula after a prior surgery. Two other case reports 
by Kim et al. and Nomiya et al. describe patients with 
refractory endometriosis treated with radiation tar-
geted to endometriotic tissue [7, 8]. These patients, 
47 and 39 years of age, were deemed to be nonviable 
surgical candidates due to severe idiopathic throm-
bocytopenic purpura and exhaustion of surgical op-
tions, respectively. Kim et al. reported treatment with 
30 Gy in 10 fractions [8], as in our case, while Nomi-
ya et al. administered 20 Gy in 10 fractions followed 
by 10 Gy in 5 fractions for residual bleeding [7]. In 
both case reports, as well as in our case, bleeding 
was successfully controlled. As in our patient, Kim 
et al. also reported resolution of pelvic pain, whereas 
Nomiya et al. did not describe this outcome. 
Management of endometriosis involves either 
hormonal therapy, surgical removal or destruction 
of endometriotic lesions, or both, depending on 
response and treatment goals [1, 4]. In cases where 
the goal is pain management and the patient is not 
currently trying to conceive, an oral contraceptive 
pill, either combined or progestin only, should be 
first line. If this treatment fails, it should be fol-
lowed by a gonadotropin-releasing hormone ago-
nist. Surgery may be considered if both hormone 
therapies fail. Surgery may be either conservative 
to the spare ovaries and uterus or definitive with 
removal of these structures, depending on de-
sire for future conception. Definitive surgery has 
a lower rate of symptom recurrence. Patients trying 
to conceive should not be treated with hormonal 
therapy and are advised to attempt to conceive 
naturally or to initiate fertility investigations or 
treatment. Non-steroidal anti-inflammatories, ac-
etaminophen, or opioids may be administered in 
addition to medical or surgical therapy for pain 
control [1, 4]. 
Management of endometriosis can be difficult 
and many patients have persistent or recurrent 
symptoms, despite medical and surgical manage-
ment [1, 5, 6]. A randomized controlled trial of 
450 women with endometriosis assigned patients to 
a medical treatment arm with 3 months of a gonad-
otropin-releasing hormone agonist, a surgical treat-
ment arm with conservative surgery, or a combined 
arm with both therapies. Recurrence of symptoms 
of dysmenorrhea, dyspareunia, or abdominal pain 
at 1-year follow up was 45% in the medical-only 
treatment arm, 50% in the surgical-only treatment 
arm, and 40% in the combined treatment arm [6]. 
A recent systematic review of treatment outcomes 
for endometriosis found that the median propor-
tion of patients with no pain reduction, with resid-
ual pain, and with a pain recurrence was 11–19%, 
5–59%, and 17–34%, respectively [5]. Finally, 
a recent review article stated approximately half of 
women treated for endometriosis have recurrent 
symptoms over a five-year period [1]. 
In our patient’s case, further surgical interven-
tion was not feasible due to her history of vesi-
covaginal fistula, leading to the consideration of 
radiation therapy. Radiation has successfully been 
used in bleeding control for several malignancies 
including gastrointestinal [13–18], lung [19, 20], 
and genitourinary tumors [17, 21, 22]. Radiation is 
also currently used in a number of benign diseases, 
including hyperproliferative and inflammatory dis-
Figure 2. radiation treatment plan. ct scan coronal 
view shows isodose lines detailing patient’s radiation 
prescription of 30 Gy in 10 fractions with 10 MV and 18 MV 
photons to the target
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ease [23]; however, modern use of radiation for 
bleeding control of benign diseases is not well re-
ported. Other than the endometriosis case reports 
previously mentioned, we only identified one other 
case report of use of radiation for bleeding control 
in a benign tumor: a 40-year-old man with repeti-
tive vitreous hemorrhage from retinal cavernous 
hemangioma treated successfully with proton beam 
therapy to 40 GyRBE in 4 sessions [24]. For our 
patient, we chose to administer external beam ra-
diation therapy as opposed to brachytherapy. Most 
studies reporting bleeding control for malignancies 
as well as the endometriosis case reports utilized 
external beam radiation as well, with the exception 
being lung tumors where there was some use of en-
dobronchial brachytherapy for hemoptysis control 
[20]. Interestingly, a wide range of fractionation 
and dose schedules of external beam appeared to 
be equally effective in bleeding control. 
There are several potential side effects involved 
in radiation treatment for endometriosis. Future 
fertility may be affected by radiation depending on 
the location of endometriotic tissue and the resul-
tant treatment field. Ovarian failure in premeno-
pausal patients and vaginal stenosis are known to 
be common gynecological complications of pel-
vic radiation [25]. Direct DNA damage to ovar-
ian follicles from ionizing radiation leads to follicle 
death and hastens the natural reduction in follicle 
number. Low follicle number results in impaired 
production of ovarian hormones, which leads to 
inadequate estrogen levels and may result in early 
menopause [26]. It has also been shown that pa-
tients treated with radiation therapy have a low but 
increased risk of secondary malignancy compared 
to the general population [27], which is an impor-
tant consideration in the utilization of radiation 
therapy for a benign condition. In the case pre-
sented here, our patient had previously been treated 
with a total abdominal hysterectomy with bilateral 
salpingo-oophorectomy and, therefore, ovarian/fer-
tility preservation was not a concern. We also made 
the patient aware of the risk of secondary malig-
nancy prior to treatment.
While not common, endometriosis can recur 
following definitive surgery with total abdominal 
hysterectomy with bilateral salpingo-oophorectomy 
[28–30]. This is likely due to incomplete removal 
of all endometriotic deposits. Additionally, lack of 
total removal of ovarian tissue can result in ovarian 
remnant syndrome, where residual ovarian tissue 
presents as a pelvic mass or pelvic pain [31, 32]. 
Either of these outcomes can cause significant pain 
and discomfort for the patient and require addi-
tional surgical and medical treatments.
From a historical perspective, radiation has 
been used successfully for bleeding control in the 
treatment of endometriosis and other benign gy-
necological diseases as far back as the early 1900s 
[33–35]. This practice peaked in the United States 
and some European countries during the 1930s, 
1940s, and 1950s. At the time, abnormal uterine 
bleeding was thought to be the result of excessive 
secretion of estrogen relative to progesterone caus-
ing anovulatory cycles, and radiation was admin-
istered with the intent of either suspending ovar-
ian endocrine function or, for women in their 40s, 
inducing menopause [33]. This practice, however, 
fell out of favor due to unnecessary risk of second-
ary malignancy and discovery of viable medical 
and surgical alternatives. History therefore serves 
as a reminder that the use of radiation for benign 
conditions must be evaluated carefully and that the 
role of radiation in treating endometriosis should 
be limited to a select group of patients for whom all 
other options have been exhausted.
This study has limitations. While all case reports 
of radiation treatment for treatment-refractory 
endometriosis reported successful outcomes, pub-
lication bias cannot be excluded; patients treated 
with radiation for endometriosis without adequate 
symptom control may not have been reported in 
the literature. Nonetheless, our patient reported 
the longest period without bleeding in 2 years and 
resolution of pelvic pain following 30 Gy in 10 frac-
tions delivered to the endometriotic tissue, and this 
case joins 2 other case reports also with successful 
outcomes.
conclusion
Vaginal bleeding secondary to refractory endo-
metriosis in the absence of surgical or medical op-
tions can be successfully treated with radiation.
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